E. A. Sausville

1.4k total citations
45 papers, 1.1k citations indexed

About

E. A. Sausville is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. A. Sausville has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. A. Sausville's work include Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Cancer therapeutics and mechanisms (4 papers). E. A. Sausville is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Cancer therapeutics and mechanisms (4 papers). E. A. Sausville collaborates with scholars based in United States, Canada and Malaysia. E. A. Sausville's co-authors include Jean Viallet, James F. Battey, Robert T. Jensen, Zahra Fathi, Richard V. Benya, Etsuko Wada, Hagit Shapira, Martha H. Corjay, David G. Covell and E S Vitetta and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

E. A. Sausville

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. A. Sausville United States 17 448 277 244 189 131 45 1.1k
Frederick O. Cope United States 17 709 1.6× 256 0.9× 101 0.4× 232 1.2× 67 0.5× 36 1.4k
J. Van Wauwe Belgium 18 583 1.3× 132 0.5× 70 0.3× 449 2.4× 54 0.4× 33 1.3k
Eric Wakshull United States 24 841 1.9× 211 0.8× 218 0.9× 594 3.1× 45 0.3× 50 1.7k
Núria Godessart Spain 21 412 0.9× 228 0.8× 37 0.2× 341 1.8× 33 0.3× 37 1.2k
Lowell M. Greenbaum United States 24 641 1.4× 201 0.7× 156 0.6× 245 1.3× 77 0.6× 67 1.6k
Francesca Buricchi Italy 20 1.0k 2.3× 154 0.6× 151 0.6× 441 2.3× 66 0.5× 32 1.7k
Cinzia Bizzarri Italy 22 673 1.5× 448 1.6× 83 0.3× 615 3.3× 69 0.5× 34 1.5k
Dinko Berkovic Germany 15 1.0k 2.3× 240 0.9× 74 0.3× 397 2.1× 43 0.3× 28 1.6k
Shuwei Li United States 21 784 1.8× 176 0.6× 40 0.2× 67 0.4× 118 0.9× 56 1.6k
Katsuji Sugie Japan 21 646 1.4× 252 0.9× 80 0.3× 817 4.3× 41 0.3× 38 1.5k

Countries citing papers authored by E. A. Sausville

Since Specialization
Citations

This map shows the geographic impact of E. A. Sausville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. A. Sausville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. A. Sausville more than expected).

Fields of papers citing papers by E. A. Sausville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. A. Sausville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. A. Sausville. The network helps show where E. A. Sausville may publish in the future.

Co-authorship network of co-authors of E. A. Sausville

This figure shows the co-authorship network connecting the top 25 collaborators of E. A. Sausville. A scholar is included among the top collaborators of E. A. Sausville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. A. Sausville. E. A. Sausville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dickson, Mark A., Patricia LoRusso, E. A. Sausville, et al.. (2011). Open-label, sequential, ascending, multi-dose, phase I study of KW-2450 as monotherapy in subjects with previously treated advanced solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3078–3078. 2 indexed citations
2.
Harb, Wael A., Barbara A. Conley, Patricia LoRusso, et al.. (2010). A phase I study of the folate-targeted conjugate EC0489 in patients with refractory or advanced metastatic cancer.. Journal of Clinical Oncology. 28(15_suppl). 3088–3088. 6 indexed citations
3.
Rosen, Peter J., E. A. Sausville, Kyriakos P. Papadopoulos, et al.. (2009). Phase II results of Study PX-171–007: A phase Ib/II study of carfilzomib (CFZ), a selective proteasome inhibitor, in patients with selected advanced metastatic solid tumors. Journal of Clinical Oncology. 27(15_suppl). 3515–3515. 5 indexed citations
4.
Sausville, E. A., et al.. (2009). A phase I study of the safety and pharmacokinetics (PK) of XMT-1001 given as an intravenous (IV) infusion once every three weeks to patients with advanced solid tumors. Journal of Clinical Oncology. 27(15_suppl). 2574–2574. 2 indexed citations
5.
Sausville, E. A., P. LoRusso, Mary Quinn, et al.. (2007). A phase I study of EC145 administered weeks 1 and 3 of a 4-week cycle in patients with refractory solid tumors. Journal of Clinical Oncology. 25(18_suppl). 2577–2577. 14 indexed citations
6.
Headlee, Donna, Yusri Elsayed, Alex Sparreboom, et al.. (2004). A first in human trial of an oral histone deacetylase inhibitor, MS-275, in advanced solid tumor and lymphoma patients.. Cancer Research. 64. 567–567. 2 indexed citations
7.
Hollingshead, Melinda G., Carrie Bonomi, Suzanne Borgel, et al.. (2004). A potential role for imaging technology in anticancer efficacy evaluations. European Journal of Cancer. 40(6). 890–898. 31 indexed citations
8.
Monga, Manish & E. A. Sausville. (2003). Developmental Therapeutics Program at the NCI: Molecular Target and Drug Discovery Process. ChemInform. 34(8). 6 indexed citations
9.
Schindler, John, E. A. Sausville, Richard A. Messmann, J W Uhr, & E S Vitetta. (2001). The toxicity of deglycosylated ricin A chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: a retrospective analysis of patients in five clinical trials.. PubMed. 7(2). 255–8. 39 indexed citations
10.
Sausville, E. A.. (2001). Scientific summation and future goals. Journal of Controlled Release. 74(1-3). 1–6. 1 indexed citations
11.
Sausville, E. A., et al.. (2000). Role of the National Cancer Institute in Acquired Immunodeficiency Syndrome-Related Drug Discovery. JNCI Monographs. 2000(28). 55–57. 2 indexed citations
12.
Dawson, Nancy A., William D. Figg, Michael R. Cooper, et al.. (1997). Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.. Journal of Clinical Oncology. 15(4). 1470–1477. 23 indexed citations
13.
Rice, William G., Jim A. Turpin, Mingjun Huang, et al.. (1997). Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nature Medicine. 3(3). 341–345. 83 indexed citations
14.
Christian, Michaele C., et al.. (1997). Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.. PubMed. 24(2). 219–40. 41 indexed citations
15.
Baluna, Roxana, E. A. Sausville, Marvin J. Stone, et al.. (1996). Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins.. PubMed. 2(10). 1705–12. 18 indexed citations
16.
Dawson, Nancy A., Michael R. Cooper, William D. Figg, et al.. (1995). Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables. Cancer. 76(3). 453–462. 63 indexed citations
17.
Sharoni, Yoav, Jean Viallet, Jane B. Trepel, & E. A. Sausville. (1991). Effect of guanine and adenine nucleotides on bombesin-stimulated phospholipase C activity in membranes from Swiss 3T3 and small cell lung carcinoma cells. Lung Cancer. 7(3). 189–189. 13 indexed citations
18.
Kohn, Elise C., Ronald G. Steis, E. A. Sausville, et al.. (1990). Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.. Journal of Clinical Oncology. 8(1). 155–160. 60 indexed citations
19.
20.
Winkler, C., E. A. Sausville, Daniel C. Ihde, et al.. (1986). Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up.. Journal of Clinical Oncology. 4(7). 1094–1100. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frederick O. Cope Breakdown of academic impact, for papers by J. Van Wauwe Breakdown of academic impact, for papers by Eric Wakshull Breakdown of academic impact, for papers by Núria Godessart Breakdown of academic impact, for papers by Lowell M. Greenbaum Breakdown of academic impact, for papers by Francesca Buricchi Breakdown of academic impact, for papers by Cinzia Bizzarri Breakdown of academic impact, for papers by Dinko Berkovic Breakdown of academic impact, for papers by Shuwei Li Breakdown of academic impact, for papers by Katsuji Sugie
Rankless by CCL
2026